1 / 2
google
Article details
- Package size
- 84
- Selling units
- 84
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
miglustatum
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
carboxymethylamylum natricum A
|
- | Substance | HNIDK |
|
povidonum K 30
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
lacca
|
- | Substance | HNIDK |
|
natrium
|
190.0 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 4883.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2005
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 56898
- Drug name
- Zavesca, Kapseln
- Galenic form
- KAPS
- ATC Code
- A16AX06
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 22/10/2004
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ZAVESCA caps 100 mg 84 pce
- Description (DE)
- ZAVESCA Kaps 100 mg 84 Stk
- Market launch
- 22/10/2004
- Narcotic (BTM)
- No
Available generics (1)
Miglustat Dipharma, capsula rigida
GTIN: 7680676330026
CHF 4422.00